TABLE 1 .
Gene category | 12 hpi versus: |
|||||||
---|---|---|---|---|---|---|---|---|
24 hpi |
48 hpi |
72 hpi |
96 hpi |
|||||
Gene | Fold change | Gene | Fold change | Gene | Fold change | Gene | Fold change | |
Upregulated | LGI1 | 8.99 | NUPR1 | 28.22 | NUPR1 | 75.32 | NUPR1 | 131.57 |
NUPR1 | 7.93 | OSTN | 10.06 | KRTAP19-1 | 16.31 | GAS5 | 64.87 | |
RPS17 | 6.69 | LGI1 | 8.73 | OSTN | 14.41 | IFIT1 | 60.32 | |
RPS29 | 4.52 | CTH | 7.41 | ASS1 | 13.82 | KRTAP19-1 | 35.33 | |
RPS3A | 4.51 | RPS17 | 7.19 | CTH | 12.2 | RPL9 | 25.02 | |
RPL9 | 4.48 | CHAC1 | 7.04 | GAS5 | 12.19 | CCNB1PIP1 | 24.6 | |
RSL24D1 | 4.39 | GAS5 | 7 | RPL9 | 10.18 | RMRP | 21.9 | |
RPL22L1 | 4.37 | IFIT1 | 6.83 | LGI1 | 9.29 | LGI1 | 20.69 | |
RPL34 | 4.26 | ASS1 | 6.65 | RSL24D1 | 9.26 | RPL26 | 20.16 | |
RPL36A | 4.23 | CCNB1PIP | 16.08 | CCNB1PIP | 18.74 | RPL39 | 19.6 | |
Downregulated | CXCL1 | 24.97 | CXCL1 | 9.14 | CYP1B1 | 16.64 | LGR5 | 14.8 |
OAS3 | 14.77 | OAS3 | 7.95 | SHISA2 | 13.81 | C22orf46 | 14.46 | |
NES | 6.07 | CYP1B1 | 6.62 | NEAT1 | 11.11 | DNAJC22 | 12.97 | |
FZD10 | 4.81 | NEAT1 | 6.22 | DOK3 | 10.79 | CYP1B1 | 12.94 | |
MAGEA3 | 4.64 | OSMR | 5.5 | FZD10 | 10.63 | CRIPAK | 12.79 | |
CYP1B1 | 4.59 | NES | 4.83 | CRIPAK | 8.54 | DOK3 | 12.73 | |
NEAT1 | 4.21 | SPEN | 4.74 | MAP1A | 8.27 | SHISA2 | 12.48 | |
SHISA2 | 3.9 | FOXD4 | 4.65 | C22orf46 | 7.22 | TRIM66 | 11.59 | |
CRIPAK | 3.81 | LGR5 | 4.64 | PCDH7 | 7.17 | TRIM56 | 11.48 | |
HLA-DOA | 3.77 | SHISA2 | 4.61 | TRIM66 | 6.65 | MAP1A | 11.16 |
A total of 519 genes were significantly differentially expressed at the intersection of all acute-phase time points, and these were analyzed with IPA to reveal those that were the most (fold change) up- or downregulated in expression at 24, 48, 72, and 96 hpi.